نتائج البحث - "Nicolas Mach"

1

Phase I/Ib Clinical Trial of Sabatolimab, an Anti-TIM-3 Antibody, Alone and in Combination with Spartalizumab, an Anti-PD-1 Antibody, in Advanced Solid Tumors

المؤلفون: Sofie Wilgenhof, Armando Santoro, Luigi Manenti, Nicolas Mach, Chia-Chi Lin, A. Xyrafas, Tyler Longmire, Patrick M. Forde, Haiying Sun, Philippe L. Bedard, Toshihiko Doi, Catherine Anne Sabatos-Peyton, Aung Naing, Hans Gelderblom, Giuseppe Curigliano, David Tai, F. Stephen Hodi, John Sarantopoulos, Sabine Gutzwiller

المصدر: Clinical Cancer Research, 27(13), 3620-3629. AMER ASSOC CANCER RESEARCH
Clinical Cancer Research, Vol. 27, No 13 (2021) pp. 3620-3629

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::936795536b936f7a14fb8e72c4462af0Test
https://hdl.handle.net/1887/3276575Test

2

SAKK 16/14: Durvalumab in Addition to Neoadjuvant Chemotherapy in Patients With Stage IIIA(N2) Non-Small Cell Lung Cancer — A Multicentre Single-Arm Phase II Trial

المصدر: SSRN Electronic Journal.

مصطلحات موضوعية: medicine.medical_specialty, Durvalumab, business.industry, Complete remission, Ethics committee, medicine.disease, Family medicine, medicine, In patient, Non small cell, Stage IIIa, Lung cancer, business, Trial registration

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::12c18aa1447293402a94207100042f9cTest
https://doi.org/10.2139/ssrn.3759708Test

3

Fibroblast growth factor receptor (FGFR) inhibitor rogaratinib in patients with advanced pretreated squamous-cell non-small cell lung cancer over-expressing FGFR mRNA: The SAKK 19/18 phase II study

المؤلفون: Eugenio Fernandez, Alfredo Addeo, Nicolas Mach, Sacha I. Rothschild, Eric I. Eboulet, Laetitia A. Mauti, Martin Frueh, Michael Mark, Christine Waibel-Pachinger, Markus Joerger, Simon Haefliger, Gilles Godar

المصدر: Journal of Clinical Oncology. 39:e21119-e21119

مصطلحات موضوعية: Cancer Research, Messenger RNA, Lung, business.industry, Cell, Phases of clinical research, medicine.disease, medicine.anatomical_structure, Oncology, Fibroblast growth factor receptor, medicine, Cancer research, In patient, Non small cell, Lung cancer, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::3fb716285b728d7b6e848b1430bb5defTest
https://doi.org/10.1200/jco.2021.39.15_suppl.e21119Test

4

Phase (Ph) II study of MBG453 + spartalizumab in patients (pts) with non-small cell lung cancer (NSCLC) and melanoma pretreated with anti–PD-1/L1 therapy

المؤلفون: Tyler Longmire, C-C. Lin, Nicolas Mach, Sofie Wilgenhof, D.W.M. Tai, Armando Santoro, A. Xyrafas, Giuseppe Curigliano, Sabine Gutzwiller, Luigi Manenti, Stephen Hodi, Toshihiko Doi, Dong Wook Kim, Haiying Sun

المصدر: Publons

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::311695050ea203189cc316e557115467Test
https://doi.org/10.1093/annonc/mdz253.028Test

5

Pembrolizumab (pembro) for recurrent head and neck squamous cell carcinoma (HNSCC): Post hoc analyses of phase 3 KEYNOTE-040 prior radiation treatment (RT) and disease state

المؤلفون: Ranee Mehra, Denis Soulières, Jonathan D. Cheng, José Dinis, Ezra E.W. Cohen, Barbara Burtness, Christophe Le Tourneau, Jianxin Lin, Nicolas Mach, Jean-Pascal Machiels, Ainara Soria, Kevin J. Harrington, Ramona F. Swaby, Lisa Licitra, Myung-Ju Ahn

المصدر: Journal of Clinical Oncology. 37:6026-6026

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::c92faa47d9315acbaa8612e553ff57e8Test
https://doi.org/10.1200/jco.2019.37.15_suppl.6026Test

6

Early clinical experience with the pan-FGFR inhibitor rogaratinib in patients with non-small cell lung cancer selected based on FGFR mRNA expression levels

المؤلفون: Bhumsuk Keam, Peter Ellinghaus, Byoung Chul Cho, Cristina Caballero, Markus Joerger, Ross A. Soo, Nicolas Mach, Manfred P. Wirth, Ana-Maria Piciu, Cyrus Sayehli, Alejandro Navarro, Sebastian Bender, Hendrik Nogai, Martin Schuler

المصدر: Journal of Clinical Oncology. 37:e20661-e20661

مصطلحات موضوعية: Cancer Research, business.industry, Mrna expression, Medizin, FGFR1 gene, medicine.disease, stomatognathic diseases, 03 medical and health sciences, 0302 clinical medicine, Oncology, Fibroblast growth factor receptor, 030220 oncology & carcinogenesis, Cancer research, Medicine, In patient, Non small cell, business, Lung cancer, 030215 immunology

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e2d2cb6634007e191cc013115b062edTest
https://doi.org/10.1200/jco.2019.37.15_suppl.e20661Test

7

Safety and preliminary efficacy of talimogene laherparepvec (T-VEC) in combination (combo) with pembrobrolizumab (Pembro) in patients (pts) with recurrent or metastatic squamous cell carcinoma of the head and neck (R/M HNSCC): A multicenter, phase 1b study (MASTERKEY-232)

المؤلفون: Tamara Rordorf, Anthony Hee Kong, Jason Chesney, Jenny J. Kim, Jesus Corral Jaime, Vittoria Espeli, Burak Gumuscu, Kevin J. Harrington, Nicolas Mach, Sheryl Treichel

المصدر: Journal of Clinical Oncology. 36:6036-6036

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::005d1298798973f6e0b4118835556c3bTest
https://doi.org/10.1200/jco.2018.36.15_suppl.6036Test

8

Phase I Trial of Concomitant Hyperfractionated Radiotherapy with Docetaxel and Cisplatin for Locally Advanced Head and Neck Cancer

المؤلفون: Minerva Becker, Nicolas Mach, Pavel Dulguerov, Abdelkarim S. Allal, Daniel Zwahlen

المصدر: Cancer Journal, Vol. 12, No 1 (2006) pp. 63-8

مصطلحات موضوعية: Male, Oncology, Cancer Research, Antineoplastic Combined Chemotherapy Protocols/administration & dosage/adverse effects, medicine.medical_treatment, Mucositis/etiology, Docetaxel, Antineoplastic Combined Chemotherapy Protocols, Dose Fractionation, ddc:616, Cisplatin/administration & dosage/adverse effects, Middle Aged, Combined Modality Therapy, Treatment Outcome, Head and Neck Neoplasms, Carcinoma, Squamous Cell, Neck Dissection, Female, Taxoids, medicine.drug, Mucositis, medicine.medical_specialty, Maximum Tolerated Dose, Locally advanced, ddc:616.0757, Head and Neck Neoplasms/pathology/therapy, Internal medicine, medicine, Humans, In patient, Aged, Neoplasm Staging, Cisplatin, Taxoids/administration & dosage/adverse effects, Dose-Response Relationship, Drug, business.industry, Deglutition Disorders/etiology, Head and neck cancer, medicine.disease, Carcinoma, Squamous Cell/pathology/therapy, Hyperfractionated radiotherapy, Radiation therapy, Concomitant, Dose Fractionation, Radiation, Deglutition Disorders, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e73b6bab1740134ab497244745b4c87Test
https://doi.org/10.1097/00130404-200601000-00011Test

9

First-in-human trial focusing on the immunologic effects of the survivin-derived multiepitope vaccine EMD640744

المؤلفون: Cristiana Sessa, Juergen Zieschang, Alexander Knuth, Steffen Boehm, Thomas Woelfel, Adrian F. Ochsenbein, Stefanie Gross, E. Gallerani, Eckhart Kaempgen, Ulf Forssmann, Volker Lennerz, Nicolas Mach, Ulrike Gnad-Vogt, L. von Boehmer, D. Hess

المصدر: Journal of Clinical Oncology. 29:2515-2515

مصطلحات موضوعية: Cancer Research, business.industry, medicine.medical_treatment, Immunogenicity, Tumor cells, First in human, Oncology, Cancer immunotherapy, Antigen, Survivin, Cancer research, Medicine, In patient, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::f1498e3c2ac9fba37994095df24d6972Test
https://doi.org/10.1200/jco.2011.29.15_suppl.2515Test

10

Phase I trial of concomitant hyperfractionated radiotherapy with docetaxel and cisplatin for locally advanced head and neck carcinomas

المؤلفون: Daniel R. Zwahlen, Pavel Dulguerov, Nicolas Mach, M. Becker, Abdelkarim S. Allal

المصدر: Journal of Clinical Oncology. 23:5574-5574

مصطلحات موضوعية: Oncology, Cisplatin, Cancer Research, medicine.medical_specialty, business.industry, Locally advanced, Hyperfractionated radiotherapy, Docetaxel, Concomitant, Maximum tolerated dose, Internal medicine, medicine, In patient, business, Head and neck, therapeutics, neoplasms, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::07fce240f816fba0636aeba9f710e59cTest
https://doi.org/10.1200/jco.2005.23.16_suppl.5574Test

تنقيح النتائج